SWOG clinical trial number
SWOG-8829
Evaluation of Amonafide in the Treatment of CNS Tumors
Closed
Phase
Accrual
97%
Published
Abbreviated Title
Evaluation of Amonafide in the Treatment of CNS Tumors
Activated
03/15/1989
Closed
12/01/1990
Publication Information Expand/Collapse
2002
Phase II trial of amonafide in central nervous system tumors: a Southwest Oncology Group study